Literature DB >> 24062354

Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans.

Maria T Vamvini1, Konstantinos N Aronis, Grigorios Panagiotou, Joo Young Huh, John P Chamberland, Mary T Brinkoetter, Michael Petrou, Costas A Christophi, Stefanos N Kales, David C Christiani, Christos S Mantzoros.   

Abstract

OBJECTIVE: Skeletal muscle is considered to be an endocrine organ that secretes a number of myokines including follistatin (FST), myostatin (MSTN), activin A, and the newly identified irisin. Irisin's biology and function exhibit similarities with the functions of the FST-MSTN-activin A axis. It remains unknown whether there is any interplay among these molecules. The aim of this study is to examine potential associations of irisin with the FST, MSTN, and activin A axis.
METHODS: Two observational studies were performed to evaluate the associations of irisin with the other three peptides. Study A included 150 healthy males aged 18.48±0.16 years with BMI 23.18±3.75 kg/m(2). Fasting serum samples were used to measure the levels of the molecules of interest. Study B included 14 morbidly obese individuals, candidates for bariatric surgery, aged 53.14±8.93 years with BMI 50.18±10.63 kg/m(2). Blood samples were obtained after an overnight fast. Eight out of the 14 participants consented to an optional thigh biopsy during their bariatric surgery. Using the above blood and tissue samples, we measured circulating levels and muscle mRNA of irisin, FST, MSTN, and activin A.
RESULTS: We report that FNDC5 mRNA in muscle is positively correlated with FST mRNA expression in morbidly obese subjects (ρ=0.93, P<0.001). We also found that circulating irisin is positively correlated with FST circulating levels among lean subjects (ρ=0.17, P=0.05) while this association was suggestive among the obese (ρ=0.56, P=0.07).
CONCLUSION: The newly identified myokine irisin may be positively associated with FST at both the mRNA and circulating protein level.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24062354      PMCID: PMC3857961          DOI: 10.1530/EJE-13-0276

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  29 in total

Review 1.  Inhibins, activins and follistatin in reproduction.

Authors:  D M de Kretser; M P Hedger; K L Loveland; D J Phillips
Journal:  Hum Reprod Update       Date:  2002 Nov-Dec       Impact factor: 15.610

2.  Medicine. Irisin, light my fire.

Authors:  Daniel P Kelly
Journal:  Science       Date:  2012-04-06       Impact factor: 47.728

Review 3.  Muscles, exercise and obesity: skeletal muscle as a secretory organ.

Authors:  Bente K Pedersen; Mark A Febbraio
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

4.  Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes.

Authors:  Fabian Sanchis-Gomar; Giuseppe Lippi; Sara Mayero; Carme Perez-Quilis; José L García-Giménez
Journal:  J Diabetes       Date:  2012-09       Impact factor: 4.006

Review 5.  Activins in adipogenesis and obesity.

Authors:  C Dani
Journal:  Int J Obes (Lond)       Date:  2012-02-28       Impact factor: 5.095

6.  Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study.

Authors:  Ole-Petter R Hamnvik; Xiaowen Liu; Michael Petrou; Huizhi Gong; John P Chamberland; Esther H Kim; Costas A Christophi; Stefanos N Kales; David C Christiani; Christos S Mantzoros
Journal:  Metabolism       Date:  2010-11-05       Impact factor: 8.694

7.  Exercise training does not increase muscle FNDC5 protein or mRNA expression in pigs.

Authors:  John N Fain; Joseph M Company; Frank W Booth; M Harold Laughlin; Jaume Padilla; Nathan T Jenkins; Suleiman W Bahouth; Harold S Sacks
Journal:  Metabolism       Date:  2013-07-05       Impact factor: 8.694

8.  Lower circulating irisin is associated with type 2 diabetes mellitus.

Authors:  Jian-Jun Liu; Melvin D S Wong; Wan Ching Toy; Clara S H Tan; Sylvia Liu; Xiao Wei Ng; Subramaniam Tavintharan; Chee Fang Sum; Su Chi Lim
Journal:  J Diabetes Complications       Date:  2013-04-22       Impact factor: 2.852

Review 9.  The regulation of interleukin-6 implicates skeletal muscle as an integrative stress sensor and endocrine organ.

Authors:  Steven S Welc; Thomas L Clanton
Journal:  Exp Physiol       Date:  2012-08-31       Impact factor: 2.969

10.  A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.

Authors:  Pontus Boström; Jun Wu; Mark P Jedrychowski; Anisha Korde; Li Ye; James C Lo; Kyle A Rasbach; Elisabeth Almer Boström; Jang Hyun Choi; Jonathan Z Long; Shingo Kajimura; Maria Cristina Zingaretti; Birgitte F Vind; Hua Tu; Saverio Cinti; Kurt Højlund; Steven P Gygi; Bruce M Spiegelman
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

View more
  19 in total

1.  Metabolism: Irisin, the metabolic syndrome and follistatin in humans.

Authors:  Pontus A Boström; José Manuel Fernández-Real
Journal:  Nat Rev Endocrinol       Date:  2013-11-19       Impact factor: 43.330

2.  Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk.

Authors:  Grigorios Panagiotou; Lin Mu; Brian Na; Kenneth J Mukamal; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-06-09       Impact factor: 8.694

3.  Irisin, a Novel Myokine, Regulates Glucose Uptake in Skeletal Muscle Cells via AMPK.

Authors:  Hye Jeong Lee; Jung Ok Lee; Nami Kim; Joong Kwan Kim; Hyung Ip Kim; Yong Woo Lee; Su Jin Kim; Jong-Il Choi; Yoonji Oh; Jeong Hyun Kim; Sun Hwa Park; Hyeon Soo Kim
Journal:  Mol Endocrinol       Date:  2015-03-31

4.  FNDC5 (irisin) gene and exceptional longevity: a functional replication study with rs16835198 and rs726344 SNPs.

Authors:  Fabian Sanchis-Gomar; Nuria Garatachea; Zi-hong He; Helios Pareja-Galeano; Noriyuki Fuku; Ye Tian; Yasumichi Arai; Yukiko Abe; Haruka Murakami; Motohiko Miyachi; Thomas Yvert; Catalina Santiago; Letizia Venturini; Carmen Fiuza-Luces; Alejandro Santos-Lozano; Gabriel Rodríguez-Romo; Giovanni Ricevuti; Nobuyoshi Hirose; Enzo Emanuele; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2014-11-27

5.  Irisin promotes cardiac progenitor cell-induced myocardial repair and functional improvement in infarcted heart.

Authors:  Yu Tina Zhao; Jianguo Wang; Naohiro Yano; Ling X Zhang; Hao Wang; Shouyan Zhang; Gangjian Qin; Patrycja M Dubielecka; Shougang Zhuang; Paul Y Liu; Y Eugene Chin; Ting C Zhao
Journal:  J Cell Physiol       Date:  2018-09-01       Impact factor: 6.384

6.  Association of serum irisin concentrations with the presence and severity of obstructive sleep apnea syndrome.

Authors:  Yanli Li; Xueqin Li; Dejun Sun; Shaoxi Cai
Journal:  J Clin Lab Anal       Date:  2016-10-11       Impact factor: 2.352

7.  Activin A and follistatin in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Athanasios D Anastasilakis; Georgios Α Triantafyllou; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-25       Impact factor: 8.694

8.  Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events.

Authors:  K N Aronis; M Moreno; S A Polyzos; J M Moreno-Navarrete; W Ricart; E Delgado; J de la Hera; A Sahin-Efe; J P Chamberland; R Berman; A Spiro; P Vokonas; J M Fernández-Real; C S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2013-06-11       Impact factor: 5.095

9.  Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice.

Authors:  A Rodríguez; S Becerril; L Méndez-Giménez; B Ramírez; N Sáinz; V Catalán; J Gómez-Ambrosi; G Frühbeck
Journal:  Int J Obes (Lond)       Date:  2014-09-09       Impact factor: 5.095

10.  Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines.

Authors:  Yae Matsuo; Konstanze Gleitsmann; Norman Mangner; Sarah Werner; Tina Fischer; T Scott Bowen; Angela Kricke; Yasuharu Matsumoto; Masahiko Kurabayashi; Gerhard Schuler; Axel Linke; Volker Adams
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-03-31       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.